Harga saham Zevra Therapeutics (ZVRA) hari ini, pre-market & after-hours

Data

Superchart

Legend

Lebih

Cari

Zevra Therapeutics, Inc.

ZVRA

Nasdaq

Health Technology

Pharmaceuticals: Major

9.71

USD

+0.185

+1.94%

Ditutup: 07-27 20:00 (UTC+0)

9.69

USD

-0.02

-0.21%

Setelah jam pasar: 07-27 20:35 (UTC+0)

ZVRA Statistik Utama

Tinggi

9.99

Buka

9.53

Volume

1.51M

Rendah

9.47

Cierre anterior

9.53

Nilai Perdagangan

14.76M

Tertinggi 52M

15.04

Volume relatif

0.961

Amplitudo (%)

5.46%

Terendah 52M

7.16

Tingkat Perputaran

2.57%

Kap Pasar

563.07M

P/E (TTM)

4.42

P/E (Tahunan)

6.807

P/B

2.74

P/S

4.61

Laba per Saham (EPS)

2.154

Dividen (TTM)

Imbal Hasil Dividen

0.00%

Saham beredar

59.11M

Mata uang

USD

ZVRA Kinerja Harga

7 hari

30 hari

90 hari

180 hari

Sejak awal tahun

1 Tahun

ZVRA Distribusi Arus Dana

ZVRA Volume Short Sale Harian

ZVRA Riwayat Short Interest

ZVRA Snapshot Saham

As of 2026-07-27, the Zevra Therapeutics, Inc. (ZVRA) stock price today is 9.71. Based on this price, the company has a market capitalization of $563.07M, with a P/E ratio of 4.42. On 2026-07-27, ZVRA traded between 9.47 and 9.99. Today’s stock price is 2.53% above the daily low and 2.80% below the daily high, placing ZVRA di sekitar bagian tengah de its most recent trading range. Trading volume currently stands at 1.51M, compared with an average daily volume of 1.58M. This suggests that trading activity is kira-kira sejalan dengan level biasanya than usual. Over the past year, Zevra Therapeutics, Inc. shares have traded between 7.16 and 15.04. At today’s price, ZVRA is 35.61% above its 52-week low and 35.44% below its 52-week high.

ZVRA Berita terkait

Tentang ZVRA

Nama Perusahaan

Zevra Therapeutics, Inc.

Sektor

Health Technology

Industri

Pharmaceuticals: Major

Bursa

Nasdaq

Jumlah Karyawan

Ukuran Lot

100

Situs resmi

www.zevra.com

Mata uang

USD

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Related Stocks

ZVRA FAQ

1.What is the live stock price of Zevra Therapeutics, Inc. (ZVRA) today?

3. What is the latest pre-market price of ZVRA?

5.How has ZVRA’s stock price performed recently?

7. What is the current capital flow for ZVRA?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Zevra Therapeutics, Inc.?

13. What is Zevra Therapeutics, Inc.’s earnings per share (EPS)?

15. Does Zevra Therapeutics, Inc. pay dividends?

17. How many employees does Zevra Therapeutics, Inc. have?

2. What were ZVRA’s trading range and trading volume on the most recent trading day?

4.What is ZVRA’s after-hours price?

6. What are ZVRA’s 52-week high and 52-week low?

8. What are ZVRA’s short sale volume and short interest?

10. What are Zevra Therapeutics, Inc.’s P/E ratio and valuation metrics?

12. What were Zevra Therapeutics, Inc.’s revenue and net income in the most recent quarter?

14.What is Zevra Therapeutics, Inc.’s total number of shares outstanding?

16. Which exchange is Zevra Therapeutics, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in ZVRA?